Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial

Tasci, Tolga; ŞÜKÜR, YAVUZ; ÖZMEN, BATUHAN; ATABEKOĞLU, CEM; Cengiz, Sevim; Kocbulut, Evren; BERKER, BÜLENT; SÖNMEZER, MURAT

doi:10.1016/j.ejogrb.2014.02.034

Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial

Tasci T., ŞÜKÜR Y. E., ÖZMEN B., ATABEKOĞLU C. S., Cengiz S. D., Kocbulut E., ...Daha Fazla

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.176, ss.50-54, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 176
Basım Tarihi: 2014
Doi Numarası: 10.1016/j.ejogrb.2014.02.034
Dergi Adı: EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.50-54
Anahtar Kelimeler: Homocysteine, Hormone replacement therapy, Lipid profile, Monocyte chemoattractant protein-1, Transdermal, VASCULAR INFLAMMATORY MARKERS, HEALTHY POSTMENOPAUSAL WOMEN, ESTROGEN PLUS PROGESTIN, CORONARY-HEART-DISEASE, C-REACTIVE PROTEIN, PLASMA HOMOCYSTEINE, MCP-1 EXPRESSION, ESTRADIOL, RISK, ATHEROSCLEROSIS
Ankara Üniversitesi Adresli: Evet

Özet

Objectives: To assess the effects of oral and transdermal hormone replacement therapies (HRT) on levels of important cardiovascular disease (CVD) markers, MCP-1 and homocyteine, in the early postmenopausal period.